Literature DB >> 1546866

Generalized myositis in Behçet disease: treatment with cyclosporine.

T Lingenfelser1, H Duerk, A Stevens, T Grossmann, M Knorr, J G Saal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1546866     DOI： 10.7326/0003-4819-116-8-651

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  [Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].

Authors:  M Krämer; M W Baumgärtel; E Neuen-Jacob; P Berlit
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

2.  Muscle involvement in two Behçet cases: magnetic resonance imaging and histology findings.

Authors:  Sedat Yilmaz; Hatice Tuba Sanal; Muhammet Cinar; Yildirim Karslıoglu
Journal:  Jpn J Radiol       Date:  2014-01-23       Impact factor: 2.374

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Myonecrosis of Behcet's disease.

Authors:  Alana Y Stubbs; Mihra S Taljanovic; Brandon Z Massey; Anna R Graham; Christopher J Friend; Joshua A Walsh
Journal:  Skeletal Radiol       Date:  2008-02-08       Impact factor: 2.199

5.  Muscular atrophy and weakness in the lower extremities in Behçet's disease: A case report and review of literature.

Authors:  Koh-Woon Kim; Jae-Heung Cho
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

6.  Lipid Storage Myopathy in Behçet's Disease: A Rare Cause of Elevated Serum Creatine Kinases Levels.

Authors:  Sedat Yilmaz; Muhammet Cinar; Yıldırım Karslioglu; Ismail Simsek; Hakan Erdem; Salih Pay; Ayhan Dinc
Journal:  Case Rep Rheumatol       Date:  2012-06-28

Review 7.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.